This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Poised for Breakouts

Supernus Pharmaceuticals

One stock that's trading very close to triggering a major breakout trade is Supernus Pharmaceuticals (SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. This stock has been on fire so far in 2012, with shares up a whopping 120%.

>>4 Biotech Stocks Under $10 Moving Higher

This company has a catalyst on the horizon, since it has a PDUFA date on Oct. 19 for the possible approval for Trokendi XR, a once-daily extended release formulation of topiramate for epilepsy. (PDUFA stands for the FDA's Prescription Drug User Fee Act.) A PDUFA date is the date on which the FDA has agreed to make a decision on the regulatory approval or rejection of a new drug's marketability in the U.S. based on efficacy and safety data from clinical trials.

If you take a look at the chart for Supernus Pharmaceuticals, you'll notice that this stock has just started to trend back above its 50-day moving average of $11.98, which is bullish technical price action. That move is quickly pushing SUPN within range of taking out some near-term overhead resistance levels.

Traders should consider long-biased trades in SUPN once it manages to break out above some near-term overhead resistance levels at $13.51 $14.15 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 89,279 shares. If that breakout triggers soon, then SUPN will have a great chance of re-testing or possibly taking out its next major overhead resistance level at $16.68 a share. Due to the PDUFA coming up shortly, the stock will have a great chance of taking $16.68 out if momentum traders pile into the stock ahead of the FDA meeting.

One could look to buy SUPN off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $11.98 a share. One could also buy off strength once SUPN starts trending above $13.51 to $14.15 a share with high volume and then simply use a stop right below $12.85 a share.

2 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,139.48 -33.20 -0.19%
S&P 500 1,994.12 -0.17 -0.01%
NASDAQ 4,533.1750 +5.4860 0.12%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs